Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited

Abstract

Phase IIa randomized double-blind, placebo-controlled study of inhaled apomorphine as acute challenge for rescuing 'off' periods in patients with established Parkinson's disease